Mark Stenhouse Insider Profile
4 Followers
Mark Stenhouse, Director at Phathom Pharmaceuticals, holds 54.12K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Prometheus Biosciences (Ticker: RXDX), holds 29.93K shares in Exact Sciences (Ticker: EXAS).
Mark Stenhouse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Mark Stenhouse holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark Stenhouse
Mark Stenhouse's Trading History
Phathom Pharmaceuticals
May 21, 2026
Director
Uninformative Buy
―
$510.37K
Prometheus Biosciences
Jun 16, 2023
―
Uninformative Sell
―
$0.00
Exact Sciences
Apr 06, 2020
―
Uninformative Buy
751.80K
$3.14M
List of latest transactions for each holding click on a transaction to see Mark Stenhouse's performance on stock
You May Also Like
Mark Stenhouse insider profile FAQ
What is the percentage of profitable transactions made by Mark Stenhouse?
The percentage of profitable transactions made by Mark Stenhouse is ―.
What is the average return per transaction made by Mark Stenhouse?
The average return per transaction made by Mark Stenhouse is ―.
What stocks does Mark Stenhouse hold?
Mark Stenhouse holds: PHAT, RXDX, EXAS stocks.
What was Mark Stenhouse’s latest transaction?
Mark Stenhouse latest transaction was an Uninformative Buy of ―.
What was Mark Stenhouse's most profitable transaction?
Mark Stenhouse’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Stenhouse's role in Phathom Pharmaceuticals?
Mark Stenhouse's role in Phathom Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.